Table 2.
Summary of quantitative article outcomes
| Advance care planning | Costs | Death location | Hospice use | Hospital use | Knowledge | Quality of life | Symptoms | |
|---|---|---|---|---|---|---|---|---|
| Early intervention | ||||||||
| McNamara (2013) [18] | Y | |||||||
| Webel (2018) [20] | N | M | N | M | ||||
| Wright (2018) [17] | Y | M | ||||||
| Qureshi (2019) [19] | Y | |||||||
| Mittmann (2020) [82] | Y | Y | ||||||
| Education | ||||||||
| Connolly (2018) [22] | Y | |||||||
| Gardner* (2022) [30] | M | |||||||
| Harrison* (2016) [27] | Y | |||||||
| Kelley (2004) [24] | Y | |||||||
| Pesut* (2015) [26] | Y | |||||||
| Claxton-Oldfield (2022) [33] | Y | |||||||
| Innovative approaches (service) | ||||||||
| Carey (2017) [54] [respite service] | Y | M | ||||||
| Ghesquiere (2018) [60] [ageing services palliative care screening tool] | Y | |||||||
| Itoh (2021) [63] [financial incentives for advanced care management] | N | |||||||
| Landers (2014) [62] [portable ultrasonography] | Y | |||||||
| Wowchuk (2009) [61] [palliative medication kit] | Y | |||||||
| Murakami (2018) [25] [community outreach, information sharing and education programme] | Y | |||||||
| Innovative approaches (personnel role) | ||||||||
| Daley* (2006) [66] [heart failure nurse-led collaboration] | N | |||||||
| Fedel* (2021) [67] [nurse specialist collaboration role with palliative care] | N | |||||||
| Fischer (2018) [70] [culturally tailored patient navigator] | Y | N | N | N | N | |||
| Moreton (2020) [64] [nurse-led specialist community palliative care model] | Y | Y | M | N | ||||
| van de Mortel (2017) [68] [general practitioner communication palliative care team facilitator] | Y | Y | ||||||
| Sussman (2011) [65] [oncology nurse-led coordinator] | Y | |||||||
| Standardised sessions | ||||||||
| Burnod (2012) [40] | Y | |||||||
| Di Pollina (2017) [41] | Y | Y | N | |||||
| Abernethy (2013) [28] | Y | Y | N | |||||
| Fletcher* (2008) [83] | Y | |||||||
| Spettell (2009) [42] | Y | Y | ||||||
| Telehealth | ||||||||
| Jiang* (2020) [36] | Y | M | ||||||
| Nguyen (2020) [39] | Y | N | N | |||||
| Riggs (2017) [38] | Y | |||||||
| Saysell* (2003) [37] | N | |||||||
| Tieman (2016) [34] | Y | |||||||
| Volunteers | ||||||||
| Lee* (2020) [45] | Y | |||||||
| Luijkx* (2009) [46] | Y | |||||||
| Pesut* (2018) [47] | Y |
Y = approach significantly improved outcome, N = approach did not significantly improve outcome, M = approach had mixed results on outcome. The studies are listed under their main component of focus; therefore, the total study counts may not exactly match those of the ‘Component examined’ section of Table 1.
aStudies are both quantitative and qualitative.